<DOC>
	<DOC>NCT00627094</DOC>
	<brief_summary>The objective of this investigation is to demonstrate the effectiveness and safety of Biatain Ibu non-adhesive foam dressing compared to Biatain non-adhesive foam dressing.</brief_summary>
	<brief_title>Biatain Ibu vs. Biatain in Painful Chronic Venous Leg Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<criteria>&gt;= 18 years of age Chronic venous leg ulcer on the lower leg Ulcer duration &gt;= 8 weeks Pain intensity in study ulcer at least 4 on an 11point numerical box scale (NBS): 0= no pain, 10= worst possible pain Exudate level moderate to high Ulcer size min 1.6 cm and max 11 cm in any direction Ankle/brachial index &gt;= 0.8 Treated with moist wound healing during the past 2 weeks prior to inclusion Adequate compression therapy during the past 2 weeks prior to inclusion The patient is cognitive capable of evaluating his/her pain relief and pain intensity The patient is able to understand the treatment and is willing to comply with the treatment regimen. The patient is able to complete the patient diary The patient is willing and able to give written informed consent Painful ulcers that have been treatment resistant to analgesics for the past 6 months or more Pregnant or lactating women Known and verified hypersensitivity to any content of the products used in this investigation Local infection (bacterial imbalanced wound) in the study ulcer Clinical infection in the study ulcer Diseases: Vasculitis, erysipelas and cellulitis of the periulcer skin The investigator considers the patient not eligible Diseases and conditions where ibuprofen or other analgesics are contraindicated (including known hypersensitivity to Aspirin (acetylsalicylic acid) or other analgesics, especially associated with a history of asthma, rhinitis or urticaria) Diabetes Use of per need medication for the past 3 days Concomitant treatment with systemic antibiotics other than nitrofurantoin Concomitant treatment with systemic corticosteroids (more than 10 mg/day prednisolon or equivalent) or other immunosuppressants within 1 month prior to inclusion Concomitant treatment with cancer chemotherapeutics Concomitant participation in other studies Previous participation in this study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>